HCA Healthcare opened higher at $480.34, compared with its previous close of $478.08. In the last trading session, the stock traded between $475.53 and $485.73. It showed a sideways intraday trend.
An investment of $100 made 5 years ago in HCA Healthcare is now worth
$ 191.81
giving a profit of
$ 91.81 (91.81%)
Note: Past profits do not guarantee future returns.
Rating from 17 Analysts
Today's Change
+$2.33 (+0.49%)
Day High
$485.73
Day Low
$475.53
Day Open
$480.34
Prev Close
$478.08
Volume
4,27,708
1W Return
2.84%
1M Return
11.32%
3M Return
17.73%
6M Return
10.50%
1Y Return
2.56%
Market Cap ($ Mn)
1,04,010
PE Ratio
14.01
PB Ratio
-
PEG Ratio
0.91
ROE
-
ROCE
27.41%
EPS (TTM)
$7.24
1 Week
2.84%
1 Month
11.32%
3 Months
17.73%
6 Months
10.50%
9 Months
-0.44%
Pomerantz probes HCA Healthcare after guidance cut and stock drop
Pomerantz LLP investigates HCA Healthcare for potential securities fraud. Full-year 2026 profit guidance lowered due to unfavorable payer mix shift. Q2 2026 revenue impacted by approximately $400 million from payer mix issues. HCA stock fell 6.95% to close at $363.60 per share on July 14, 2026.
16 days agoPomerantz investigates HCA Healthcare over securities fraud claims
Pomerantz LLP is investigating HCA Healthcare for potential securities fraud. HCA lowered full-2026 profit guidance on July 14, 2026, citing unfavorable payer mix. The payer mix shift impacted Q2 revenue by approximately $400 million. HCA stock fell $27.14, or 6.95%, to close at $363.60 following the announcement.
1mo agoMeditech Expanse live across 34 HCA Healthcare hospitals in two U.S. divisions
Meditech Expanse EHR now live across 34 hospitals in HCA Healthcare’s Capital and North Florida divisions. These are the first two U.S. divisions of the 15-division network to fully implement the platform. Total hospitals running on Expanse reach 72 across the U.S. and U.K. as of August 2026. Next wave of hospital implementations planned for October 2026.
1mo agoPomerantz probes HCA Healthcare over fraud claims after guidance cut
Pomerantz LLP investigates HCA Healthcare for potential securities fraud. HCA lowered full-2026 profit guidance citing unfavorable payer mix shifts. Payer mix changes impacted Q2 2026 revenue by approximately $400 million. Stock fell 6.95% to $363.60 per share on July 14, 2026.
1mo agoHCA Healthcare to present at Wells Fargo, Jefferies conferences in September
HCA Healthcare to present at Wells Fargo conference on September 9, 2026, at 10:15 am ET. Company also scheduled for Jefferies conference on September 15, 2026, at 1:50 pm CT. Live webcasts and presentation materials available via investor relations website. HCA operates 190 hospitals and ~2,600 ambulatory sites in 19 states and UK.
2mo agoPomerantz LLP probes HCA Healthcare over $400M revenue miss
Pomerantz LLP leads a probe into HCA Healthcare's disclosures after a $400M revenue hit and guidance cut in Q2FY26. Multiple law firms are investigating potential securities fraud as the stock fell nearly 7%.
2mo ago| Stock | LTP | Change % | Market Cap | PE |
|---|---|---|---|---|
| $310.34 | -2.35% | $50,246.84M | 45.36 | |
| $270.57 | +0.77% | $21,786.03M | 10.31 | |
| $77.84 | +1.61% | $13,793.09M | - | |
| $131.49 | +7.70% | $12,971.88M | 20.21 | |
| $23.13 | +2.25% | $12,423.82M | 11.93 | |
| $193.31 | +5.10% | $12,333.18M | 15.26 | |
| $60.22 | +1.28% | $11,915.37M | 52.31 | |
| $186.32 | +1.20% | $10,870.10M | 27.11 | |
| $176.61 | +2.57% | $9,128.62M | 7.00 | |
| $101.36 | +0.02% | $8,383.99M | 34.79 | |
| $49.68 | +1.26% | $7,866.13M | 25.00 | |
| $116.90 | +1.41% | $7,302.63M | 28.83 |
An investment of $100 made 5 years ago in HCA Healthcare is now worth
$ 191.81
giving a profit of
$ 91.81 (91.81%)
Note: Past profits do not guarantee future returns.
